About Fluidigm Corporation (NASDAQ:FLDM)
Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company's core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment. Its products include preparatory instruments, preparatory analytical instruments, analytical instruments, integrated fluidic circuits (IFCs), and assays and reagents. Its preparatory instruments include C1 Single-Cell Auto Prep System, Access Array System, Juno System and IFCs, and Callisto System and IFC. Its analytical instruments include Biomark HD System, EP1 System and Helios/CyTOF 2 System. Its assays and reagents include Delta Gene and SNP Type Assays, and Access Array Target-Specific Primers and Targeted Sequencing Prep Primers.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Software & Technology Services
- Sub-Industry: Life Sciences Tools & Services
- Symbol: NASDAQ:FLDM
- CUSIP: 34385P10
- Web: www.fluidigm.com
Capitalization:- Market Cap: $147.95 million
- Outstanding Shares: 29,414,000
Average Prices:- 50 Day Moving Avg: $4.98
- 200 Day Moving Avg: $4.50
- 52 Week Range: $2.52 - $8.69
P/E:- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -3.87
- P/E Growth: 0.28
Sales & Book Value:- Annual Revenue: $96.72 million
- Price / Sales: 1.53
- Book Value: $0.81 per share
- Price / Book: 6.21
Profitability:- EBITDA: ($62,620,000.00)
- Net Margins: -74.05%
- Return on Equity: -121.04%
- Return on Assets: -18.55%
Debt:- Debt-to-Equity Ratio: 8.15%
- Current Ratio: 2.31%
- Quick Ratio: 1.76%
Misc:- Average Volume: 371,789 shs.
- Beta: 3.37
- Short Ratio: 14.31
Frequently Asked Questions for Fluidigm Corporation (NASDAQ:FLDM)
What is Fluidigm Corporation's stock symbol?
Fluidigm Corporation trades on the NASDAQ under the ticker symbol "FLDM."
How were Fluidigm Corporation's earnings last quarter?
Fluidigm Corporation (NASDAQ:FLDM) announced its quarterly earnings data on Thursday, August, 3rd. The company reported ($0.58) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.60) by $0.02. The company had revenue of $23.90 million for the quarter, compared to analysts' expectations of $23.50 million. Fluidigm Corporation had a negative net margin of 74.05% and a negative return on equity of 121.04%. Fluidigm Corporation's revenue was down 15.2% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.63) EPS. View Fluidigm Corporation's Earnings History.
When will Fluidigm Corporation make its next earnings announcement?
Where is Fluidigm Corporation's stock going? Where will Fluidigm Corporation's stock price be in 2017?
1 brokers have issued 12-month price targets for Fluidigm Corporation's stock. Their predictions range from $9.00 to $9.00. On average, they anticipate Fluidigm Corporation's share price to reach $9.00 in the next twelve months. View Analyst Ratings for Fluidigm Corporation.
Who are some of Fluidigm Corporation's key competitors?
Some companies that are related to Fluidigm Corporation include Sientra (SIEN), Arrowhead Pharmaceuticals (ARWR), Forward Pharma A/S (FWP), Utah Medical Products (UTMD), Kura Oncology (KURA), RTI Surgical (RTIX), Protagonist Therapeutics (PTGX), Syndax Pharmaceuticals (SNDX), Aratana Therapeutics (PETX), Ardelyx (ARDX), Stemline Therapeutics (STML), NanoString Technologies (NSTG), Enzymotec (ENZY), Foamix Pharmaceuticals (FOMX), Biodel (ALBO), Mirna Therapeutics (SYBX), Vital Therapies (VTL) and Threshold Pharmaceuticals (MTEM).
Who are Fluidigm Corporation's key executives?
Fluidigm Corporation's management team includes the folowing people:
- Samuel D. Colella, Independent Chairman of the Board
- Stephen Christopher Linthwaite, President, Chief Executive Officer, Chief Operating Officer, Director
- Vikram Jog, Chief Financial Officer
- William Maxwell Smith J.D., Executive Vice President - Legal Affairs, General Counsel, Secretary
- Robert C. Jones, Executive Vice President - Research and Development
- Jennifer Ling Lee, Principal Accounting Officer, Vice President, Controller
- Mai Chan Yow, Executive Vice President - Worldwide Manufacturing and Managing Director
- Nicolas M. Barthelemy, Director
- Carlos V. Paya M.D., Ph.D., Director
- Gerhard F. Burbach, Independent Director
Who owns Fluidigm Corporation stock?
Fluidigm Corporation's stock is owned by many different of retail and institutional investors. Top institutional shareholders include
LEVIN CAPITAL STRATEGIES, L.P.
(29.60%). Company insiders that own Fluidigm Corporation stock include Evan/ Fa Jones, Levin Capital Strategies, LP, Samuel D Colella, Stephen Christopher Linthwaite and Steven Mcphail. View Institutional Ownership Trends for Fluidigm Corporation.
How do I buy Fluidigm Corporation stock?
Shares of Fluidigm Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Fluidigm Corporation's stock price today?
One share of Fluidigm Corporation stock can currently be purchased for approximately $5.03.
MarketBeat Community Rating for Fluidigm Corporation (NASDAQ FLDM)MarketBeat's community ratings are surveys of what our community members think about Fluidigm Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Earnings History for Fluidigm Corporation (NASDAQ:FLDM)Earnings History by Quarter for Fluidigm Corporation (NASDAQ FLDM)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 11/2/2017 | | ($0.31) | | | | | N/A |  |
| 8/3/2017 | Q2 2017 | ($0.60) | ($0.58) | $23.50 million | $23.90 million | View | Listen | |
| 2/8/2017 | Q4 2016 | ($0.61) | ($0.61) | $25.91 million | $25.10 million | View | Listen | |
| 11/3/2016 | Q3 | ($0.67) | ($0.68) | $27.75 million | $22.20 million | View | N/A | |
| 8/4/2016 | Q2 | ($0.58) | ($0.64) | $29.62 million | $28.20 million | View | N/A | |
| 5/5/2016 | Q116 | ($0.53) | ($0.40) | $26.95 million | $29.00 million | View | N/A | |
| 10/29/2015 | Q315 | ($0.55) | ($0.15) | $27.54 million | $28.60 million | View | Listen | |
| 8/6/2015 | Q215 | ($0.48) | ($0.53) | $30.43 million | $28.62 million | View | Listen | |
| 5/7/2015 | Q115 | ($0.40) | ($0.39) | $30.70 million | $26.70 million | View | Listen | |
| 2/5/2015 | Q414 | ($0.43) | ($0.39) | $33.34 million | $33.50 million | View | Listen | |
| 10/30/2014 | Q314 | ($0.04) | ($0.49) | $29.20 million | $29.60 million | View | N/A | |
| 7/31/2014 | Q214 | ($0.50) | ($0.45) | $27.13 million | $27.60 million | View | N/A | |
| 2/6/2014 | Q413 | ($0.15) | ($0.04) | $20.73 million | $20.90 million | View | N/A | |
| 10/30/2013 | Q313 | ($0.20) | ($0.06) | $16.70 million | $18.30 million | View | N/A | |
| 8/1/2013 | Q2 2013 | ($0.17) | ($0.07) | $15.87 million | $17.50 million | View | N/A | |
| 11/7/2012 | Q312 | ($0.21) | ($0.12) | $13.35 million | $12.60 million | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Fluidigm Corporation (NASDAQ:FLDM)Current Year EPS Consensus Estimate: $-1.95 EPS
Next Year EPS Consensus Estimate: $-1.30 EPS
Dividend History for Fluidigm Corporation (NASDAQ:FLDM)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Fluidigm Corporation (NASDAQ:FLDM)Insider Ownership Percentage: 4.70%
Institutional Ownership Percentage: 88.85%
Insider Trades by Quarter for Fluidigm Corporation (NASDAQ:FLDM)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 10/10/2017 | Levin Capital Strategies, L.P. | Insider | Buy | 95,843 | $4.57 | $438,002.51 | |
| 10/9/2017 | Levin Capital Strategies, L.P. | Insider | Buy | 50,000 | $4.59 | $229,500.00 | |
| 9/12/2017 | Levin Capital Strategies, L.P. | Insider | Buy | 60,000 | $5.25 | $315,000.00 | |
| 8/17/2017 | Levin Capital Strategies, L.P. | Insider | Buy | 465 | $3.66 | $1,701.90 | |
| 8/10/2017 | Levin Capital Strategies, L.P. | Insider | Buy | 4,003,129 | $3.30 | $13,210,325.70 | |
| 8/9/2017 | Levin Capital Strategies, L.P. | Insider | Buy | 1,549 | $3.18 | $4,925.82 | |
| 8/8/2017 | Samuel D Colella | Director | Buy | 35,895 | $2.77 | $99,429.15 | |
| 8/8/2017 | Stephen Christopher Linthwaite | CEO | Buy | 45,000 | $2.66 | $119,700.00 | |
| 8/8/2017 | Steven Mcphail | Insider | Buy | 20,000 | $3.00 | $60,000.00 | |
| 6/7/2017 | Evan/ Fa Jones | Director | Sell | 10,900 | $4.54 | $49,486.00 | |
| 5/9/2017 | Samuel D Colella | Director | Buy | 7,500 | $5.93 | $44,475.00 | |
| 3/14/2017 | Samuel D Colella | Director | Buy | 10,000 | $5.00 | $50,000.00 | |
| 12/14/2016 | Samuel D Colella | Director | Buy | 5,000 | $7.39 | $36,950.00 | |
| 11/30/2016 | Samuel D Colella | Director | Buy | 20,000 | $6.32 | $126,400.00 | |
| 11/30/2016 | Stephen Christopher Linthwaite | CEO | Buy | 55,000 | $6.36 | $349,800.00 | |
| 11/7/2016 | Levin Capital Strategies, L.P. | Insider | Buy | 159,200 | $4.44 | $706,848.00 | |
| 11/2/2016 | Levin Capital Strategies, L.P. | Insider | Buy | 48,302 | $4.44 | $214,460.88 | |
| 10/1/2015 | Gajus Vincent Worthington | CEO | Sell | 6,000 | $8.05 | $48,300.00 | |
| 9/2/2015 | Gajus Vincent Worthington | CEO | Sell | 12,000 | $11.53 | $138,360.00 | |
| 6/16/2015 | Vikram Jog | CFO | Sell | 3,550 | $25.00 | $88,750.00 | |
| 6/15/2015 | William Maxwell Smith | EVP | Sell | 3,000 | $24.20 | $72,600.00 | |
| 6/1/2015 | Gajus Vincent Worthington | CEO | Sell | 6,000 | $23.71 | $142,260.00 | |
| 4/20/2015 | Mai Chan Yow | Insider | Sell | 15,300 | $44.73 | $684,369.00 | |
| 4/17/2015 | Mai Chan Yow | Insider | Sell | 4,700 | $44.04 | $206,988.00 | |
| 4/17/2015 | William Maxwell Smith | EVP | Sell | 3,000 | $43.05 | $129,150.00 | |
| 4/8/2015 | Mai Chan Yow | Insider | Sell | 30,000 | $42.67 | $1,280,100.00 | |
| 4/7/2015 | Vikram Jog | CFO | Sell | 3,950 | $40.81 | $161,199.50 | |
| 4/1/2015 | Gajus Vincent Worthington | CEO | Sell | 6,000 | $40.02 | $240,120.00 | |
| 4/1/2015 | Robert C Jones | EVP | Sell | 3,000 | $41.63 | $124,890.00 | |
| 3/16/2015 | William Maxwell Smith | EVP | Sell | 3,000 | $40.87 | $122,610.00 | |
| 3/9/2015 | Vikram Jog | CFO | Sell | 3,950 | $41.48 | $163,846.00 | |
| 3/2/2015 | Evan/ Fa Jones | Director | Sell | 7,500 | $44.15 | $331,125.00 | |
| 3/2/2015 | Gajus Vincent Worthington | CEO | Sell | 6,000 | $43.77 | $262,620.00 | |
| 3/2/2015 | Robert C Jones | EVP | Sell | 3,000 | $43.78 | $131,340.00 | |
| 2/20/2015 | Samuel D Colella | Director | Sell | 44,540 | $38.97 | $1,735,723.80 | |
| 2/2/2015 | Gajus Vincent Worthington | CEO | Sell | 6,000 | $38.15 | $228,900.00 | |
| 1/15/2015 | William Maxwell Smith | EVP | Sell | 3,000 | $34.24 | $102,720.00 | |
| 1/2/2015 | Gajus Vincent Worthington | CEO | Sell | 6,000 | $33.37 | $200,220.00 | |
| 12/15/2014 | William Maxwell Smith | EVP | Sell | 3,000 | $27.20 | $81,600.00 | |
| 12/12/2014 | Evan/ Fa Jones | Director | Sell | 8,352 | $27.44 | $229,178.88 | |
| 12/9/2014 | Evan/ Fa Jones | Director | Sell | 3,336 | $28.34 | $94,542.24 | |
| 12/8/2014 | Evan/ Fa Jones | Director | Sell | 1,000 | $29.06 | $29,060.00 | |
| 12/8/2014 | Vikram Jog | CFO | Sell | 3,950 | $29.07 | $114,826.50 | |
| 12/1/2014 | Gajus Vincent Worthington | CEO | Sell | 6,000 | $30.03 | $180,180.00 | |
| 11/17/2014 | William Maxwell Smith | EVP | Sell | 3,000 | $29.52 | $88,560.00 | |
| 11/12/2014 | Evan/ Fa Jones | Director | Sell | 5,000 | $29.55 | $147,750.00 | |
| 11/7/2014 | Vikram Jog | CFO | Sell | 3,950 | $29.45 | $116,327.50 | |
| 10/24/2014 | Mai Chan Yow | Insider | Sell | 10,000 | $28.00 | $280,000.00 | |
| 10/7/2014 | Vikram Jog | CFO | Sell | 3,950 | $22.65 | $89,467.50 | |
| 9/15/2014 | William Maxwell Smith | EVP | Sell | 3,000 | $30.83 | $92,490.00 | |
| 9/8/2014 | Vikram Jog | CFO | Sell | 3,950 | $28.57 | $112,851.50 | |
| 9/2/2014 | Gajus Vincent Worthington | CEO | Sell | 6,000 | $28.16 | $168,960.00 | |
| 8/7/2014 | Vikram Jog | CFO | Sell | 3,733 | $26.34 | $98,327.22 | |
| 8/6/2014 | Gajus Vincent Worthington | CEO | Sell | 6,000 | $26.53 | $159,180.00 | |
| 7/15/2014 | William Maxwell Smith | EVP | Sell | 3,000 | $31.98 | $95,940.00 | |
| 7/7/2014 | Vikram Jog | CFO | Sell | 5,427 | $30.61 | $166,120.47 | |
| 7/1/2014 | Gajus Vincent Worthington | CEO | Sell | 6,000 | $29.72 | $178,320.00 | |
| 6/16/2014 | William Maxwell Smith | EVP | Sell | 3,000 | $27.64 | $82,920.00 | |
| 6/2/2014 | Gajus Vincent Worthington | CEO | Sell | 6,000 | $26.55 | $159,300.00 | |
| 5/15/2014 | William Maxwell Smith | EVP | Sell | 3,000 | $28.53 | $85,590.00 | |
| 5/8/2014 | Gajus Vincent Worthington | CEO | Sell | 6,000 | $32.14 | $192,840.00 | |
| 4/15/2014 | William Maxwell Smith | EVP | Sell | 3,000 | $35.32 | $105,960.00 | |
| 4/7/2014 | Vikram Jog | CFO | Sell | 5,091 | $37.51 | $190,963.41 | |
| 3/17/2014 | William Maxwell Smith | EVP | Sell | 3,000 | $47.76 | $143,280.00 | |
| 11/6/2013 | Gajus Vincent Worthington | CEO | Sell | 11,832 | $30.03 | $355,314.96 | |
| 9/3/2013 | Gajus Vincent Worthington | CEO | Sell | 10,000 | $20.53 | $205,300.00 | |
| 9/3/2013 | William Maxwell Smith | EVP | Sell | 7,000 | $20.42 | $142,940.00 | |
| 8/30/2013 | Robert Jones | EVP | Sell | 3,500 | $20.36 | $71,260.00 | |
| 8/14/2013 | Samuel Colella | Director | Sell | 23,192 | $19.91 | $461,752.72 | |
| 8/8/2013 | William Maxwell Smith | EVP | Sell | 16,000 | $20.02 | $320,320.00 | |
| 8/6/2013 | Gajus Vincent Worthington | CEO | Sell | 10,000 | $19.49 | $194,900.00 | |
| 8/6/2013 | Robert Jones | EVP | Sell | 3,500 | $19.16 | $67,060.00 | |
| 7/8/2013 | Vikram Jog | CFO | Sell | 5,661 | $17.05 | $96,520.05 | |
| 7/1/2013 | Gajus Vincent Worthington | CEO | Sell | 10,000 | $17.14 | $171,400.00 | |
| 7/1/2013 | William Maxwell Smith | EVP | Sell | 5,000 | $17.11 | $85,550.00 | |
| 6/28/2013 | Robert C Jones | EVP | Sell | 3,500 | $17.11 | $59,885.00 | |
| 6/7/2013 | Vikram Jog | CFO | Sell | 5,661 | $16.00 | $90,576.00 | |
| 6/3/2013 | Gajus Vincent Worthington | CEO | Sell | 10,000 | $17.00 | $170,000.00 | |
| 6/3/2013 | William Maxwell Smith | Insider | Sell | 5,000 | $16.96 | $84,800.00 | |
| 5/31/2013 | Robert C Jones | EVP | Sell | 3,500 | $16.93 | $59,255.00 | |
| 3/4/2013 | Mai Chan Yow | Insider | Sell | 30,000 | $18.15 | $544,500.00 | |
| 2/4/2013 | Robert C Jones | EVP | Sell | 6,984 | $16.61 | $116,004.24 | |
| 2/1/2013 | Gajus Vincent Worthington | CEO | Sell | 10,000 | $16.60 | $166,000.00 | |
| 12/28/2012 | William Maxwell Smith | Insider | Sell | 4,504 | $14.11 | $63,551.44 | |
| 12/26/2012 | William Maxwell Smith | Insider | Sell | 6,756 | $14.36 | $97,016.16 | |
| 12/14/2012 | Evan/ Fa Jones | Director | Buy | 10,000 | $14.36 | $143,600.00 | |
| 12/11/2012 | Evan/ Fa Jones | Director | Buy | 1,971 | $14.00 | $27,594.00 | |
| 12/5/2012 | William Maxwell Smith | EVP | Sell | 6,756 | $14.25 | $96,273.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Fluidigm Corporation (NASDAQ:FLDM)
Latest Headlines for Fluidigm Corporation (NASDAQ:FLDM)
| Source: |
|
| Date | Headline |
|---|
 | Fluidigm to Report Q3 2017 Financial Results and Host Conference Call
finance.yahoo.com - October 19 at 7:25 PM |
| Fluidigm to Unveil High-Parameter Tissue Imaging System
finance.yahoo.com - October 18 at 8:06 PM |
 | athenahealth (ATHN) vs. Fluidigm Corporation (FLDM) Critical Review
www.americanbankingnews.com - October 12 at 6:46 AM |
| ETFs with exposure to Fluidigm Corp. : October 11, 2017
finance.yahoo.com - October 11 at 8:18 PM |
| Fluidigm Corporation (FLDM) Insider Purchases $229,500.00 in Stock
www.americanbankingnews.com - October 11 at 7:52 PM |
| Insider Buying: Fluidigm Corporation (FLDM) Insider Acquires 95,843 Shares of Stock
www.americanbankingnews.com - October 11 at 7:50 PM |
| Analyzing Fluidigm Corporation (FLDM) and Its Rivals
www.americanbankingnews.com - October 9 at 6:28 PM |
| Head-To-Head Comparison: Fluidigm Corporation (FLDM) vs. Its Rivals
www.americanbankingnews.com - October 5 at 6:24 PM |
| Should You Be Concerned About Fluidigm Corporation’s (FLDM) Risks?
finance.yahoo.com - October 2 at 2:33 PM |
| Contrasting Fluidigm Corporation (FLDM) and Simulations Plus (SLP)
www.americanbankingnews.com - September 30 at 4:20 PM |
| Financial Review: Fluidigm Corporation (FLDM) vs. The Competition
www.americanbankingnews.com - September 26 at 2:08 PM |
| Reviewing Fluidigm Corporation (FLDM) & Its Rivals
www.americanbankingnews.com - September 25 at 12:26 AM |
| Reviewing Fluidigm Corporation (FLDM) and Its Rivals
www.americanbankingnews.com - September 24 at 8:12 PM |
| Analyzing Fluidigm Corporation (FLDM) & athenahealth (ATHN)
www.americanbankingnews.com - September 23 at 4:22 AM |
| Veeva Systems (VEEV) vs. Fluidigm Corporation (FLDM) Critical Comparison
www.americanbankingnews.com - September 20 at 12:36 AM |
| Fluidigm Corporation (FLDM) vs. Its Competitors Head-To-Head Contrast
www.americanbankingnews.com - September 18 at 6:24 PM |
| Insider Buying: Fluidigm Corporation (FLDM) Insider Buys 60,000 Shares of Stock
www.americanbankingnews.com - September 14 at 11:16 PM |
| Financial Comparison: Fluidigm Corporation (FLDM) and its Rivals
www.americanbankingnews.com - September 11 at 4:22 AM |
| Financial Contrast: Omnicell (OMCL) vs. Fluidigm Corporation (FLDM)
www.americanbankingnews.com - September 8 at 6:10 AM |
| Fluidigm to Participate in Two Upcoming Health Care Conferences in September
finance.yahoo.com - August 28 at 6:24 PM |
| Short Interest in Fluidigm Corporation (FLDM) Expands By 67.9%
www.americanbankingnews.com - August 28 at 1:48 AM |
| ETFs with exposure to Fluidigm Corp. : August 25, 2017
finance.yahoo.com - August 26 at 1:09 AM |
| Fluidigm Licenses CFTR Next-Generation Sequencing Assay From Baylor Genetics for Use With the Juno System
finance.yahoo.com - August 17 at 7:56 PM |
| Fluidigm Corp. :FLDM-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017
finance.yahoo.com - August 16 at 6:46 PM |
| Fluidigm Corporation (FLDM) Insider Purchases $13,210,325.70 in Stock
www.americanbankingnews.com - August 14 at 10:30 PM |
| Head-To-Head Survey: Allscripts Healthcare Solutions (MDRX) versus Fluidigm Corporation (NASDAQ:FLDM)
www.americanbankingnews.com - August 13 at 9:00 AM |
 | Fluidigm (FLDM) Announces Sale of $30M of Common Stock in ATM Equity Offering
www.streetinsider.com - August 12 at 12:07 AM |
| Fluidigm Announces Sale of $30 Million of Common Stock in At-The-Market Equity Offering
finance.yahoo.com - August 10 at 7:59 PM |
| Fluidigm Corporation (FLDM) Insider Purchases $60,000.00 in Stock
www.americanbankingnews.com - August 8 at 10:30 PM |
| Insider Buying: Fluidigm Corporation (FLDM) CEO Acquires 45,000 Shares of Stock
www.americanbankingnews.com - August 8 at 10:30 PM |
| Insider Buying: Fluidigm Corporation (NASDAQ:FLDM) Director Buys 35,895 Shares of Stock
www.americanbankingnews.com - August 8 at 10:30 PM |
| Fluidigm Corporation (FLDM) Issues Quarterly Earnings Results
www.americanbankingnews.com - August 5 at 4:04 PM |
| Edited Transcript of FLDM earnings conference call or presentation 3-Aug-17 9:00pm GMT
finance.yahoo.com - August 4 at 6:57 PM |
| Fluidigm reports 2Q loss
finance.yahoo.com - August 4 at 6:57 PM |
| Fluidigm Announces Second Quarter Financial Results and Operational Progress
finance.yahoo.com - August 3 at 9:02 PM |
| Fluidigm Corporation Announces Termination of Tax Benefit Preservation Plan
finance.yahoo.com - August 2 at 7:32 PM |
| Analyzing Medical Transcription Billing, Corp. (MTBC) and Fluidigm Corporation (NASDAQ:FLDM)
www.americanbankingnews.com - August 2 at 6:23 PM |
| Fluidigm and Ascendas Genomics Announce Strategic Partnership to Develop Microfluidic Molecular Diagnostics in China
finance.yahoo.com - July 27 at 7:14 PM |
| Fluidigm Corporation (FLDM) Scheduled to Post Earnings on Thursday
www.americanbankingnews.com - July 27 at 10:46 AM |
 | Week 30 Breakout Forecast: Short-Term Picks To Give You An Edge
seekingalpha.com - July 22 at 7:00 PM |
| Fluidigm to Report Q2 2017 Financial Results and Host Conference Call
finance.yahoo.com - July 20 at 4:20 PM |
| Fluidigm Introduces Immuno-Oncology Gene Expression Assay for Translational and Clinical Research
finance.yahoo.com - July 18 at 8:06 PM |
| ETFs with exposure to Fluidigm Corp. : July 10, 2017
finance.yahoo.com - July 10 at 6:35 PM |
| HealthEquity (HQY) and Fluidigm Corporation (NASDAQ:FLDM) Head-To-Head Analysis
www.americanbankingnews.com - July 5 at 12:42 PM |
 | Nicolas Barthelemy and Carlos Paya Join Fluidigm Board of Directors
us.rd.yahoo.com - March 27 at 4:56 PM |
| FLUIDIGM CORP Files SEC form 10-K, Annual Report
biz.yahoo.com - March 3 at 5:15 PM |
| FLUIDIGM CORP Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - March 2 at 5:29 PM |
| 4:04 pm Fluidigm misses by $0.09, reports revs in-line; guides Q1 revs below consensus
us.rd.yahoo.com - February 8 at 10:44 PM |
| Q4 2016 Fluidigm Corp Earnings Release - After Market Close
us.rd.yahoo.com - February 8 at 5:43 PM |
| Fluidigm Announces Q4 and Full Year 2016 Financial Results
us.rd.yahoo.com - February 8 at 5:43 PM |
Fluidigm Corporation (FLDM) Chart for Saturday, October, 21, 2017
